PuSH - Publication Server of Helmholtz Zentrum München: Neocarzilin inhibits cancer cell proliferation via BST-2 degradation, resulting in lipid raft-trapped EGFR.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Braun, J.* ; Hu, Y.* ; Jauch, A.T.* ; Gronauer, T.F. ; Mergner, J.* ; Bach, N.C.* ; Traube, F.R.* ; Zahler, S.* ; Sieber, S.A.*

Neocarzilin inhibits cancer cell proliferation via BST-2 degradation, resulting in lipid raft-trapped EGFR.

JACS Au 4, 1833-1840 (2024)

DOI

PMC

Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.

Abstract
Metrics
Extra information

Neocarzilin (NCA) is a natural product exhibiting potent antimigratory as well as antiproliferative effects. While vesicle amine transport protein 1 (VAT-1) was previously shown to inhibit migration upon NCA binding, the molecular mechanisms responsible for impaired proliferation remained elusive. We here introduce a chemical probe closely resembling the structural and stereochemical features of NCA and unravel bone marrow stromal antigen 2 (BST-2) as one of the targets responsible for the antiproliferative effect of NCA in cancer cells. The antiproliferative mechanism of NCA was confirmed in corresponding BST-2 knockout (KO) HeLa cells, which were less sensitive to compound treatment. Vice versa, reconstitution of BST-2 in the KO cells again reduced proliferation upon NCA addition, comparable to that of wild-type (wt) HeLa cells. Whole proteome mass spectrometric (MS) analysis of NCA-treated wt and KO cancer cells revealed regulated pathways and showed reduced levels of BST-2 upon NCA treatment. In-depth analysis of BST-2 levels in response to proteasome and lysosome inhibitors unraveled a lysosomal degradation path upon NCA treatment. As BST-2 mediates the release of epidermal growth factor receptor (EGFR) from lipid rafts to turn on proliferation signaling pathways, reduced BST-2 levels led to attenuated phosphorylation of STAT3. Furthermore, fluorescence microscopy confirmed increased colocalization of EGFR and lipid rafts in the presence of NCA. Overall, NCA represents a versatile anticancer natural product with a unique dual mode of action and unconventional inhibition of proliferation via BST-2 degradation.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Antitumor Agents ; Biological Activity ; Mechanism Of Action ; Natural Products ; Proteomics; Tool

ISSN (print) / ISBN 2691-3704

e-ISSN 2691-3704

Journal JACS Au

Quellenangaben Volume: 4, Issue: 5, Pages: 1833-1840

Publisher American Chemical Society (ACS)

Publishing Place 1155 16th St, Nw, Washington, Dc 20036 Usa

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) CF Metabolomics & Proteomics (CF-MPC)

Grants China Scholarship Council (CSC)
China Scholarship Council
Deutsche Forschungsgemeinschaft(DFG)
Foundation of German Business